Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Joseph Mattingly

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
JAMA Health Forum|May 10, 2024
Implementing Maximum Fair Price Without Hurting PharmaciesT Joseph Mattingly, Anthony A Esterly, Anna Kaltenboeck
The New England Journal of Medicine|January 3, 2025
Leveraging Old Hepatitis C TherapiesS Sean Tu, Shyamasundaran Kottilil, T Joseph Mattingly
Journal of Managed Care & Specialty Pharmacy|January 31, 2025
Emerging trends in managed care pharmacy: A mixed-method studyT Joseph Mattingly, Laura E Happe, Laura Cranston
The Annals of Pharmacotherapy|July 19, 2017
Hepatitis C Treatment Regimens Are Cost-Effective: But Compared With What?T Joseph Mattingly, Julia F Slejko, C Daniel Mullins
Pharmacoeconomics|January 25, 2022
Correction to: Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease TherapiesT Joseph Mattingly, R Brett McQueen, Pei-Jung Lin
Research in Social & Administrative Pharmacy : RSAP|April 3, 2018
Using 340B drug discounts to provide a financially sustainable medication discharge serviceTimothy Wu, Carla Williams, Kathryn Vranek, et al.
Research in Social & Administrative Pharmacy : RSAP|May 24, 2019
Relationship between regulatory barriers to entry and pharmacy technician wagesBenjamin Y Urick, T Joseph Mattingly, Ashlee N Mattingly
Hepatology (Baltimore, Md.)|August 24, 2017
Engaging hepatitis C infected patients in cost-effectiveness analyses: A literature reviewT Joseph Mattingly, Eleanor M Perfetto, Sophia L Johnson
Research in Social & Administrative Pharmacy : RSAP|May 23, 2026
Geographic variation in pharmacy competition and social vulnerability proximate to WalgreensKwame Kissi-Twum, Kelly E Anderson, T Joseph Mattingly
Health Affairs Scholar|February 25, 2026
Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional studyT Joseph Mattingly, Emeka Elvis Duru, Rena M Conti
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
JAMA Health Forum|May 10, 2024
Implementing Maximum Fair Price Without Hurting PharmaciesT Joseph Mattingly, Anthony A Esterly, Anna Kaltenboeck
The New England Journal of Medicine|January 3, 2025
Leveraging Old Hepatitis C TherapiesS Sean Tu, Shyamasundaran Kottilil, T Joseph Mattingly
Journal of Managed Care & Specialty Pharmacy|January 31, 2025
Emerging trends in managed care pharmacy: A mixed-method studyT Joseph Mattingly, Laura E Happe, Laura Cranston
The Annals of Pharmacotherapy|July 19, 2017
Hepatitis C Treatment Regimens Are Cost-Effective: But Compared With What?T Joseph Mattingly, Julia F Slejko, C Daniel Mullins
Pharmacoeconomics|January 25, 2022
Correction to: Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease TherapiesT Joseph Mattingly, R Brett McQueen, Pei-Jung Lin
Research in Social & Administrative Pharmacy : RSAP|April 3, 2018
Using 340B drug discounts to provide a financially sustainable medication discharge serviceTimothy Wu, Carla Williams, Kathryn Vranek, et al.
Research in Social & Administrative Pharmacy : RSAP|May 24, 2019
Relationship between regulatory barriers to entry and pharmacy technician wagesBenjamin Y Urick, T Joseph Mattingly, Ashlee N Mattingly
Hepatology (Baltimore, Md.)|August 24, 2017
Engaging hepatitis C infected patients in cost-effectiveness analyses: A literature reviewT Joseph Mattingly, Eleanor M Perfetto, Sophia L Johnson
Research in Social & Administrative Pharmacy : RSAP|May 23, 2026
Geographic variation in pharmacy competition and social vulnerability proximate to WalgreensKwame Kissi-Twum, Kelly E Anderson, T Joseph Mattingly
Health Affairs Scholar|February 25, 2026
Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional studyT Joseph Mattingly, Emeka Elvis Duru, Rena M Conti
Pageof 13